Carrillo-Esper R, Zepeda-Mendoza AD, Carrillo-Córdova DM, García de Alba-Graue P, Carrillo-Córdova CA

Idioma: Español
Referencias bibliográficas: 15
Paginas: 392-396
Archivo PDF: 195.18 Kb.

RESUMEN

La coagulopatía secundaria a trauma tiene una etiología multifactorial, destacando en su génesis la pérdida sanguínea, el consumo de factores de coagulación y plaquetas, la hemodilución, inflamación, lesión endotelial, hiperfibrinólisis, hipotermia, acidosis y alteraciones metabólicas. El tratamiento de la coagulopatía secundaria a trauma se basa en el uso racional de antifibrinolíticos sistémicos, hemostáticos locales y una terapia individualizada basada en el uso de concentrados de factores de coagulación de los que destacan el concentrado de complejo protrombínico y el concentrado de factor XII.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Writin D, Di Nardo JA. TEG y ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228-232.

2. Nardi G, Agostini V, Rondinelli B, Russo B, et al. Trauma induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care. 2015;19:817-820.

3. Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007;35:2191-2195.

4. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49:2652-2660.

5. Chandler WL. Procoagulant activity in trauma patients. Am J Clin Pathol. 2010;134:90-96.

6. Maegele M, Schol H, Cohen MJ. An up-date on the coagulopathy of trauma. Shock. 2014;41:21-25.

7. Castellheim A, Brekkle OL, Espevik T, Harboe M, Mollnes TE. Innate inmune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009;69:479-491.

8. Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost. 2011;9:182-188.

9. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg. 2012;99:40-50.

10. Tauber H, Innerhofer P, Breitkopf R. Prevalence and impact of abnormal ROTEM assays in severe blunt trauma: results of the diagnosis and treatment of trauma induced coagulopathy (DIA-TRE-TIC) study. Br J Anaesth. 2011;107:378-387.

11. Kaibara M, Iwata H, Ujiie H. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrinolysis. 2005;16:355-363

12. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55.

13. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23-32.

14. Hippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360-365.

15. Fenger-Erickson C, Lindberg-Larsen M, Christensen AQ, Ingerslev J. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentration. Br J Anaesth. 2008;101:769-773.